To use this site, please disable the ad blocking feature and reload the page.
This website uses cookies to collect information about your visit for purposes such as showing you personalized ads and content, and analyzing our website traffic. By clicking “Accept all,” you will allow the use of these cookies.
Users accessing this site from EEA countries and UK are unable to view this site without your consent. We apologize for any inconvenience caused.
Yomiuri Shimbun file photo The Health, Labor and Welfare Ministry
The Yomiuri Shimbun
19:56 JST, November 22, 2022
The Health, Labor and Welfare Ministry’s meeting of experts on Tuesday decided to give emergency approval to Xocova, an oral medicine for COVID-19 developed by Shionogi & Co.
Xocova will become the country’s first domestically produced oral medicine for COVID-19 patients.
